By target indication, the obesity/chronic weight management segment is expected to expand at the fastest CAGR from 2026 to 2035
Triple-agonists are a newer type of medication that binds to and activates three distinct receptor types simultaneouslythe goal is to achieve a stronger effect
Semaglutide helps to keep blood sugar levels stable by inhibiting the release of glucagon, especially after meals
Its easy to find, available in foam or liquid, and works well for many users
GLP-1 medications, often referred to as GLP-1 agonists, are a type of medications that help manage blood sugar levels in people with Type 2 diabetes, and they are also used to treat obesity
Oral semaglutide also provides significant appetite suppression but may take longer to show results